Alpha 2.0
Login Register
» Articles » PMID: 34718478

Safety of COVID-19 Vaccination in Inflammatory Bowel Disease Patients on Biologic Therapy

Overview
Journal J Crohns Colitis
Publisher Oxford University Press
Date 2021 Oct 31
PMID 34718478
Citations 8
Authors
Isabel Garrido
Susana Lopes
Guilherme Macedo
Affiliations
Soon will be listed here.
Citing Articles

Clinical characteristics and the risk factors for the exacerbation of symptoms in patients with inflammatory bowel disease during the COVID-19 pandemic.

Wu J, Fang Y, Bai B, Wu Y, Liu Q, Hu J Front Med (Lausanne). 2024; 11:1404880.

PMID: 38903816 PMC: 11188298. DOI: 10.3389/fmed.2024.1404880.

The association of three vaccination doses with reduced gastrointestinal symptoms after severe acute respiratory syndrome coronavirus 2 infections in patients with inflammatory bowel disease.

Hong Y, Che T, Shen X, Chen J, Wang K, Zhao L Front Med (Lausanne). 2024; 11:1377926.

PMID: 38562376 PMC: 10982480. DOI: 10.3389/fmed.2024.1377926.

Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease.

Yoshida Y, Fujioka S, Moriyama T, Umeno J, Kawasaki K, Fuyuno Y Intern Med. 2023; 62(24):3579-3584.

PMID: 37779068 PMC: 10781543. DOI: 10.2169/internalmedicine.2335-23.

COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease.

Peshevska-Sekulovska M, Bakalova P, Snegarova V, Lazova S, Velikova T Vaccines (Basel). 2022; 10(12).

PMID: 36560485 PMC: 9781431. DOI: 10.3390/vaccines10122075.

Impact of Anti-TNFα Treatment on the Humoral Response to the BNT162b2 mRNA COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease Patients.

Kashiwagi K, Jimbo K, Suzuki M, Arai N, Kudo T, Shimizu T Vaccines (Basel). 2022; 10(10).

PMID: 36298483 PMC: 9611127. DOI: 10.3390/vaccines10101618.